Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

Affiliations

¹ McKinsey & Company and Diasome Pharmaceuticals, Inc., Palo Alto, CA.
² Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
³ Division of Endocrinology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA.
⁴ Joslin Diabetes Center, Harvard Medical School, Boston, MA.
⁵ Pediatric Endocrinology & Diabetes, Yale School of Medicine, New Haven, CT.
⁶ Division of Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL schatz@ufl.edu.

Practice Guideline

Jane L Chiang et al. Diabetes Care. 2018 Sep.

. 2018 Sep;41(9):2026-2044.

doi: 10.2337/dci18-0023. Epub 2018 Aug 9.

¹ McKinsey & Company and Diasome Pharmaceuticals, Inc., Palo Alto, CA.
² Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
³ Division of Endocrinology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA.
⁴ Joslin Diabetes Center, Harvard Medical School, Boston, MA.
⁵ Pediatric Endocrinology & Diabetes, Yale School of Medicine, New Haven, CT.
⁶ Division of Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL schatz@ufl.edu.

No abstract available

References

1. Silverstein J, Klingensmith G, Copeland K, et al. .; American Diabetes Association . Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28:186–212 - PubMed
1. Dabelea D, Mayer-Davis EJ, Saydah S, et al. .; SEARCH for Diabetes in Youth Study . Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014;311:1778–1786 - PMC - PubMed
1. Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. .; SEARCH for Diabetes in Youth Study . Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med 2017;376:1419–1429 - PMC - PubMed
1. Wherrett DK, Chiang JL, Delamater AM, et al. .; Type 1 Diabetes TrialNet Study Group . Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report. Diabetes Care 2015;38:1975–1985 - PMC - PubMed
1. Nadeau KJ, Anderson BJ, Berg EG, et al. . Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities. Diabetes Care 2016;39:1635–1642 - PMC - PubMed